Ipamorelin
Longevity SupportPulsatile GH restoration; IGF-1 axis support; lean mass preservation; sleep architecture improvement
GHRP-2
AdjacentResearch ongoing — see primary literature for current evidence.
Clinical Decision Framework
When evaluating Ipamorelin versus GHRP-2 for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize Ipamorelin:
Select Ipamorelin when the primary clinical objective aligns with its core mechanism: selective ghrelin receptor (ghsr) agonist that stimulates pulsatile gh release with minimal effect on cortisol or prolactin.. This is particularly relevant for protocols focused on selective gh release with a favorable safety profile and minimal side effects..
When to prioritize GHRP-2:
Conversely, GHRP-2 is the superior choice when targeting potent ghsr agonist that strongly stimulates gh release and moderately increases cortisol and prolactin., making it the preferred agent for strong gh release with appetite stimulation..
Begin Your Age Reversal Protocol for Ipamorelin or GHRP-2
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing